BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21597375)

  • 21. Biomarkers in connective tissue disease-associated interstitial lung disease.
    Bonella F; Costabel U
    Semin Respir Crit Care Med; 2014 Apr; 35(2):181-200. PubMed ID: 24668534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias.
    Tzelepis GE; Toya SP; Moutsopoulos HM
    Eur Respir J; 2008 Jan; 31(1):11-20. PubMed ID: 18166591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review.
    Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP
    Autoimmun Rev; 2020 Feb; 19(2):102453. PubMed ID: 31838163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal interstitial lung disease induced by rituximab-containing chemotherapy, treatment with TNF-α antagonist and cytokine profiling: a case-report and review of the literature.
    Wu Y; Jia Y; Xu J; Shuai X; Wu Y
    J Clin Pharm Ther; 2013 Jun; 38(3):249-53. PubMed ID: 23506410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.
    Kocheril SV; Appleton BE; Somers EC; Kazerooni EA; Flaherty KR; Martinez FJ; Gross BH; Crofford LJ
    Arthritis Rheum; 2005 Aug; 53(4):549-57. PubMed ID: 16082627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rituximab in connective tissue disorders related interstitial lung disease.
    Lepri G; Avouac J; Airò P; Anguita Santos F; Bellando-Randone S; Blagojevic J; Garcia Hernàndez F; Gonzalez Nieto JA; Guiducci S; Jordan S; Limaye V; Maurer B; Selva-O'Callaghan A; Riccieri V; Distler O; Matucci-Cerinic M; Allanore Y
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):181-185. PubMed ID: 27749242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Air pollutants and development of interstitial lung disease in patients with connective tissue disease: a population-based case-control study in Taiwan.
    Chen HH; Yong YM; Lin CH; Chen YH; Chen DY; Ying JC; Chao WC
    BMJ Open; 2020 Dec; 10(12):e041405. PubMed ID: 33372076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interstitial lung disease and anti-TNF-alpha therapy in rheumatoid arthritis: Two different patterns?].
    Schuller A; Coudurier M; Lega JC; Khouatra C; Cottin V; Cordier JF
    Rev Mal Respir; 2010 Mar; 27(3):232-7. PubMed ID: 20359615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary arterial hypertension complicating connective tissue diseases.
    Hassoun PM
    Semin Respir Crit Care Med; 2009 Aug; 30(4):429-39. PubMed ID: 19634082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab-induced interstitial lung disease.
    Wagner SA; Mehta AC; Laber DA
    Am J Hematol; 2007 Oct; 82(10):916-9. PubMed ID: 17597477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease.
    Wolfe F; Caplan L; Michaud K
    Scand J Rheumatol; 2007; 36(3):172-8. PubMed ID: 17657669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
    Bérezné A; Valeyre D; Ranque B; Guillevin L; Mouthon L
    Ann N Y Acad Sci; 2007 Sep; 1110():271-84. PubMed ID: 17911442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement.
    Antoniou KM; Margaritopoulos G; Economidou F; Siafakas NM
    Eur Respir J; 2009 Apr; 33(4):882-96. PubMed ID: 19336591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determining respiratory impairment in connective tissue disease-associated interstitial lung disease.
    Assayag D; Ryerson CJ
    Rheum Dis Clin North Am; 2015 May; 41(2):213-23. PubMed ID: 25836638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-disciplinary collaboration in connective tissue disease-related lung disease.
    Fischer A; Richeldi L
    Semin Respir Crit Care Med; 2014 Apr; 35(2):159-65. PubMed ID: 24668532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD).
    O'Dwyer DN; Armstrong ME; Cooke G; Dodd JD; Veale DJ; Donnelly SC
    Eur J Intern Med; 2013 Oct; 24(7):597-603. PubMed ID: 23916467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
    Harigai M; Hara M; Kamatani N; Kashiwazaki S
    Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary biliary cirrhosis complicated with interstitial lung disease: a prospective study in 178 patients.
    Shen M; Zhang F; Zhang X
    J Clin Gastroenterol; 2009 Aug; 43(7):676-9. PubMed ID: 19247207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus.
    Sumida H; Asano Y; Tamaki Z; Aozasa N; Taniguchi T; Takahashi T; Toyama T; Ichimura Y; Noda S; Akamata K; Miyazaki M; Kuwano Y; Yanaba K; Sato S
    J Dermatol; 2014 May; 41(5):418-20. PubMed ID: 24801917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased incidence of autoantibodies to interleukin-1a in rheumatoid arthritis with interstitial lung disease.
    Maniwa K; Ogushi F; Tani K; Ohmoto Y; Muraguchi M; Sone S
    Respirology; 2000 Dec; 5(4):315-20. PubMed ID: 11192540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.